Title : Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril.

Pub. Date : 1996 Jan 15

PMID : 8548907






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. candesartan cilexetil angiotensinogen Rattus norvegicus